NYSE:MDS Midas (MDS) Stock Price, News & Analysis → Write this ticker symbol down… (From StocksToTrade) (Ad) Free MDS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Midas alerts: Email Address Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… About MidasMidas, Inc. (MDS) is engaged in the business of selling automotive repair franchises. The Midas network of franchised and company operated shops is a provider of automotive repair and maintenance services in North America with 1,538 shops located in all 50 states of United States and nine Canadian provinces as of January 2, 2011. The SpeeDee network of franchised and company operated shops consists of 106 shops in the United States, located in 10 states. In addition, both Midas and SpeeDee license their brands outside of North America. There are 781 Midas shops licensed in 13 other countries and 65 licensed SpeeDee shops in Mexico. On a worldwide basis, there were 2,490 Midas and SpeeDee shops as of January 2, 2011.Read More Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… MDS Stock News HeadlinesJanuary 30, 2023 | finance.yahoo.comGlobal Myelodysplastic Syndrome (MDS) Drugs Market to Reach $3 Billion by 2027January 10, 2023 | thestreet.comMidas Stock Soars (MDS)January 7, 2023 | bbc.co.ukMrs MidasOctober 15, 2022 | msn.comSask. artist Henry Ripplinger dead at 83; remembered as dauntless, larger than lifeAugust 23, 2022 | ca.finance.yahoo.comProactive news headlines including Corazon Mining, Magmatic Resources, Carnavale Resources and Australian VanadiumAugust 22, 2022 | proactiveinvestors.com.auCarnavale Resources divests Barracuda nickel-copper-PGE project to maintain West Australian gold focusAugust 19, 2022 | stockhouse.comCG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic AdenocarcinomaJune 10, 2022 | dailymail.co.ukRobin Roberts recalls coming out fears, admitting she didn't think she 'could be Christian and gay'January 19, 2022 | thestreet.comMarket Preview: Will March Come In Like a Bear This Year?September 17, 2021 | au.finance.yahoo.comOutdoor Living Brand Outer Raises $50M in Series B FundingSee More Headlines Receive MDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Midas and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:MDS CUSIPN/A CIK1046131 Webwww.midas.com Phone+1-630-4383000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report MDS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Midas own? Based on aggregate information from My MarketBeat watchlists, some companies that other Midas investors own include NioCorp Developments (NB), Midas Gold Corp. (MAX.TO) (MAX) and Lida Resources (LDDAF). This page (NYSE:MDS) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityStansberry ResearchThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Midas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.